Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
28.00
-0.49 (-1.72%)
Oct 6, 2025, 3:06 PM EDT - Market open
Moderna Stock Forecast
Stock Price Forecast
The 15 analysts that cover Moderna stock have a consensus rating of "Hold" and an average price target of $42.4, which forecasts a 51.43% increase in the stock price over the next year. The lowest target is $15 and the highest is $70.
Price Target: $42.4 (+51.43%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 22, 2025.
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 14 | 13 | 13 | 13 | 12 | 10 |
Sell | 3 | 3 | 3 | 3 | 4 | 4 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 20 | 19 | 19 | 19 | 19 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Sell Maintains $18 → $15 | Sell | Maintains | $18 → $15 | -46.43% | Aug 22, 2025 |
Barclays | Barclays | Hold Maintains $40 → $31 | Hold | Maintains | $40 → $31 | +10.71% | Aug 4, 2025 |
JP Morgan | JP Morgan | Sell Maintains $33 → $26 | Sell | Maintains | $33 → $26 | -7.14% | May 22, 2025 |
UBS | UBS | Strong Buy Maintains $78 → $70 | Strong Buy | Maintains | $78 → $70 | +150.00% | May 2, 2025 |
Barclays | Barclays | Hold Maintains $45 → $40 | Hold | Maintains | $45 → $40 | +42.86% | May 2, 2025 |
Financial Forecast
Revenue This Year
1.96B
from 3.24B
Decreased by -39.49%
Revenue Next Year
2.15B
from 1.96B
Increased by 9.75%
EPS This Year
-9.98
from -9.28
EPS Next Year
-8.07
from -9.98
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.4B | 3.2B | |||
Avg | 2.0B | 2.1B | |||
Low | 1.5B | 1.3B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -26.1% | 61.7% | |||
Avg | -39.5% | 9.8% | |||
Low | -53.3% | -32.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -9.18 | -6.00 | |||
Avg | -9.98 | -8.07 | |||
Low | -10.50 | -9.93 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | |||
Avg | - | - | |||
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.